CLINICAL FEATURES AND OUTCOMES OF PAEDIATRIC PATIENTS WITH ISOLATED COLONIC CROHN'S DISEASE: A MULTICENTRE STUDY FROM THE PAEDIATRIC IBD PORTO GROUP OF ESPGHAN. (22nd January 2022)

• Record Type: Journal Article
• Authors: Berger, Tal; Lee, Huey Miin; Padmanaban, Lavenya Ramasamy; Wine, Eytan; Yerushalmy-Feler, Anat; Hojsak, Iva; Kazeka, Denis; Serban, Daniela Elena; Yogev, Dotan; Ledder, Oren; Lionetti, Paolo; Scarallo, Luca; Gasparetto, Marco; Croft, Nicholas M; Miele, Erasmo; Staiano, Annamaria; Meredith, Joseph; Aloi, Marina; Alvisi, Patrizia; Urlep, Darja; Weiss, Batia; Malham, Mikkel; Matar, Manar; Navas-López, Víctor; Romano, Claudio; Dipasquale, Valeria; Norsa, Lorenzo; Kolho, Kaija-Leena; Shamir, Raanan; Shouval, Dror
• Is Part Of: Inflammatory bowel diseases. Volume 28(2022)Supplement 1
• Page Start: S71
• Page End: S72
• Publication Date: 2022-01-22
• Subjects: Inflammatory bowel diseases -- Periodicals; Colitis, Ulcerative -- Periodicals; Crohn Disease -- Periodicals; Inflammatory Bowel Diseases -- Periodicals; 616.344
• DOI: 10.1093/ibd/izac015.116
• Languages: English
• ISSNs: 1078-0998

Abstract

Abstract: BACKGROUND: Adult studies suggest that patients with isolated colonic Crohn's disease (L2 CD) exhibit unique characteristics differentiating them from patients with ileo-cecal (L1) CD and ulcerative colitis (UC). We aimed to characterize clinical features and outcomes of paediatric patients with L2. METHODS: Retrospective data was collected through the Porto IBD group of ESPGHAN on paediatric patients with L2, L1 or UC at different time-points. Outcome measures included time to 1 st flare, hospital admissions, initiation of anti-TNFa drug, stricture and surgery. RESULTS: Three hundred patients were included: 102 L1, 94 L2 and 104 UC. Rates of hematochezia at presentation were 14.7%, 44.7% and 95.2%, while rates of fever were 12.7%, 26.6% and 2.9%, for patients with L1, L2 and UC, respectively (P<0.001 for all comparisons). Skip lesions were identified in 65% of patients with L2, and granulomas in 36%, similar to L1 patients. Rates of ASCA and pANCA positivity significantly differed between the groups: 25.4% and 16.7% for patients with L2, compared with 55.2% and 2.3%, and 1.8% and 52.9% for patients with L1 and UC, respectively. Response rates to exclusive enteral nutrition were comparable between L1 and L2 (78.3-82.4%), as was the response to oral steroids (70.4-76.5%) in the three groups. While times to 1 st flare and admission were similar between groups, patients with L1 were commenced on anti-TNFa earlier. Moreover, stricturing phenotype and need for colectomy were very rare in patients with L2. CONCLUSIONS: Significant differences are observed in the clinical presentation and outcomes of paediatric patients with L2, compared to patients with L1 and UC.